Search research articles
Contact Us
Filters
Showing results (21-30 of 115) with videos related to
Page
of 12
Sort By:
Diagnostics (Basel, Switzerland)
|
February 3, 2021
Prognostic Value of <sup>18</sup>F-FDG-PET Parameters in Patients with Small Cell Lung Cancer: A Meta-Analysis and Review of Current Literature
Tine Nøhr Christensen, Per Kragh Andersen, Seppo W Langer, et al.
Cancers
|
September 14, 2024
Recurrence Rates and Patterns after Radical Resection of Lung Carcinoids
Erika Askildsen, Patrick Soldath, Seppo W Langer, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
February 2, 2024
Prognostic thresholds of fluorine-18 fluorodeoxyglucose-positron emission tomography mean and maximum standardized uptake values for survival and nodal involvement in lung neuroendocrine neoplasms
Patrick Soldath, Tina Binderup, Andreas Kjaer, et al.
Expert Review of Anticancer Therapy
|
April 8, 2014
PET/CT in therapy evaluation of patients with lung cancer
Natasha Hemicke Langer, Tine Nøhr Christensen, Seppo W Langer, et al.
Integrative Cancer Therapies
|
March 25, 2015
The Impact of a Multidimensional Exercise Intervention on Physical and Functional Capacity, Anxiety, and Depression in Patients With Advanced-Stage Lung Cancer Undergoing Chemotherapy
Morten Quist, Lis Adamsen, Mikael Rørth, et al.
Diagnostics (Basel, Switzerland)
|
February 9, 2016
Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review
Emma Elizabeth Ilett, Seppo W Langer, Ingrid Holst Olsen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 3, 2021
Long-term survival and recurrence after resection of bronchopulmonary carcinoids: A single-center cohort study of 236 patients
Patrick Soldath, Tina Binderup, Andreas Kjær, et al.
Journal of Cancer
|
August 27, 2014
Topotecan monotherapy in heavily pretreated patients with progressive advanced stage neuroendocrine carcinomas
Ingrid Holst Olsen, Ulrich Knigge, Birgitte Federspiel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 21, 2022
Prospective Phase II Trial of Prognostication by <sup>68</sup>Ga-NOTA-AE105 uPAR PET in Patients with Neuroendocrine Neoplasms: Implications for uPAR-Targeted Therapy
Esben Andreas Carlsen, Mathias Loft, Annika Loft, et al.
Cancer Chemotherapy and Pharmacology
|
May 17, 2003
Metabolism of dexrazoxane (ICRF-187) used as a rescue agent in cancer patients treated with high-dose etoposide
Patricia E Schroeder, Peter Buhl Jensen, Maxwell Sehested, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 115) with videos related to
Sort By:
Page
of 12
Diagnostics (Basel, Switzerland)
|
February 3, 2021
Prognostic Value of <sup>18</sup>F-FDG-PET Parameters in Patients with Small Cell Lung Cancer: A Meta-Analysis and Review of Current Literature
Tine Nøhr Christensen, Per Kragh Andersen, Seppo W Langer, et al.
Cancers
|
September 14, 2024
Recurrence Rates and Patterns after Radical Resection of Lung Carcinoids
Erika Askildsen, Patrick Soldath, Seppo W Langer, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
February 2, 2024
Prognostic thresholds of fluorine-18 fluorodeoxyglucose-positron emission tomography mean and maximum standardized uptake values for survival and nodal involvement in lung neuroendocrine neoplasms
Patrick Soldath, Tina Binderup, Andreas Kjaer, et al.
Expert Review of Anticancer Therapy
|
April 8, 2014
PET/CT in therapy evaluation of patients with lung cancer
Natasha Hemicke Langer, Tine Nøhr Christensen, Seppo W Langer, et al.
Integrative Cancer Therapies
|
March 25, 2015
The Impact of a Multidimensional Exercise Intervention on Physical and Functional Capacity, Anxiety, and Depression in Patients With Advanced-Stage Lung Cancer Undergoing Chemotherapy
Morten Quist, Lis Adamsen, Mikael Rørth, et al.
Diagnostics (Basel, Switzerland)
|
February 9, 2016
Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review
Emma Elizabeth Ilett, Seppo W Langer, Ingrid Holst Olsen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 3, 2021
Long-term survival and recurrence after resection of bronchopulmonary carcinoids: A single-center cohort study of 236 patients
Patrick Soldath, Tina Binderup, Andreas Kjær, et al.
Journal of Cancer
|
August 27, 2014
Topotecan monotherapy in heavily pretreated patients with progressive advanced stage neuroendocrine carcinomas
Ingrid Holst Olsen, Ulrich Knigge, Birgitte Federspiel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 21, 2022
Prospective Phase II Trial of Prognostication by <sup>68</sup>Ga-NOTA-AE105 uPAR PET in Patients with Neuroendocrine Neoplasms: Implications for uPAR-Targeted Therapy
Esben Andreas Carlsen, Mathias Loft, Annika Loft, et al.
Cancer Chemotherapy and Pharmacology
|
May 17, 2003
Metabolism of dexrazoxane (ICRF-187) used as a rescue agent in cancer patients treated with high-dose etoposide
Patricia E Schroeder, Peter Buhl Jensen, Maxwell Sehested, et al.
Page
of 12